Skip to main content
Premium Trial:

Request an Annual Quote

Defense Dept. Pays ABI $24.5M to Develop Pathogen-Detection Test

NEW YORK (GenomeWeb News) — The US Department of Defense has awarded Applied Biosystems a $24.5 million contract to develop a prototype system that can identify infectious diseases for epidemiological and biosecurity purposes.
ABI said the company has already presented “key components” of the prototype to the United States Air Force, which will validate it.
According to ABI, the system will use a multiplex assay to identify emerging pathogens. Early prototypes can already ID 10 pathogens simultaneously on a test array, the firm said.
The company added that, once completed, the system could be used in other applications in biosecurity, forensics, animal testing, and food quality testing --- applied markets that ABI hopes will fatten its top line over the next two years.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.